The SALINE Technique for the Treatment of the No-Reflow Phenomenon during Percutaneous Coronary Intervention in STEMI
暂无分享,去创建一个
A. Bartorelli | P. Montorsi | G. Monizzi | A. Mastrangelo | L. Grancini | A. Galassi | B. Alushi | Davide Diana | P. Olivares | Alice Centola
[1] A. Candreva,et al. Saline-induced coronary hyperemia with continuous intracoronary thermodilution is mediated by intravascular hemolysis. , 2022, Atherosclerosis.
[2] A. Candreva,et al. Simplified Assessment of the Index of Microvascular Resistance , 2021, Journal of interventional cardiology.
[3] A. Candreva,et al. Basics of Coronary Thermodilution. , 2021, JACC. Cardiovascular interventions.
[4] A. Candreva,et al. Thermodilution-Derived Volumetric Resting Coronary Blood Flow Measurement in Humans. , 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[5] J. Bartunek,et al. Duration of Hyperemia With Intracoronary Administration of Papaverine , 2021, Journal of the American Heart Association.
[6] P. Bruneval,et al. Intracoronary Saline‐Induced Hyperemia During Coronary Thermodilution Measurements of Absolute Coronary Blood Flow: An Animal Mechanistic Study , 2020, Journal of the American Heart Association.
[7] D. Kandzari,et al. Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no‐reflow during primary PCI: The RESTORE observational study , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[8] G. Cimmino,et al. Antiplatelet therapy in Acute Coronary Syndromes. Lights and shadows of platelet function tests to guide the best therapeutic approach. , 2020, Current vascular pharmacology.
[9] I. Porto,et al. Index of Microcirculatory Resistance as a Tool to Characterize Microvascular Obstruction and to Predict Infarct Size Regression in Patients With STEMI Undergoing Primary PCI. , 2019, JACC. Cardiovascular imaging.
[10] F. Crea,et al. The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection. , 2018, Cardiovascular research.
[11] Kristian Thygesen,et al. Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.
[12] Marco Valgimigli,et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.
[13] M. Penicka,et al. Saline-Induced Coronary Hyperemia: Mechanisms and Effects on Left Ventricular Function , 2017, Circulation. Cardiovascular interventions.
[14] K. Abrams,et al. The REFLO-STEMI (REperfusion Facilitated by LOcal adjunctive therapy in ST-Elevation Myocardial Infarction) trial: a randomised controlled trial comparing intracoronary administration of adenosine or sodium nitroprusside with control for attenuation of microvascular obstruction during primary percut , 2016 .
[15] G. Heusch. The Coronary Circulation as a Target of Cardioprotection. , 2016, Circulation research.
[16] E. Ohman,et al. Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials. , 2016, Journal of the American College of Cardiology.
[17] Harlan M Krumholz,et al. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infa , 2016, Journal of the American College of Cardiology.
[18] F. Van de Werf,et al. Evolving therapies for myocardial ischemia/reperfusion injury. , 2015, Journal of the American College of Cardiology.
[19] E. Romagnoli,et al. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitropruss , 2013, JACC. Cardiovascular interventions.
[20] M. Nijsten,et al. Computer-assisted myocardial blush quantification after percutaneous coronary angioplasty for acute myocardial infarction: a substudy from the TAPAS trial. , 2009, European heart journal.
[21] F. Zijlstra,et al. Thrombus aspiration during primary percutaneous coronary intervention. , 2008, The New England journal of medicine.
[22] F. Burzotta,et al. Thrombus-aspiration: a victory in the war against no reflow , 2008, The Lancet.
[23] F. Zijlstra,et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study , 2008, The Lancet.
[24] G. Schuler,et al. Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging. , 2006, European heart journal.
[25] Hiroshi Ito. No-reflow phenomenon and prognosis in patients with acute myocardial infarction , 2006, Nature Clinical Practice Cardiovascular Medicine.
[26] Steven A. Julious,et al. Sample size of 12 per group rule of thumb for a pilot study , 2005 .
[27] E. Antman,et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. , 2005, JAMA.
[28] R. Schröder. Prognostic Impact of Early ST-Segment Resolution in Acute ST-Elevation Myocardial Infarction , 2004, Circulation.
[29] E. Braunwald,et al. Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic Administration in Acute Myocardial Infarction , 2002, Circulation.
[30] K. Okumura,et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. , 2000, Journal of the American College of Cardiology.
[31] Y. Taniyama,et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. , 1997, Journal of the American College of Cardiology.
[32] D. Baim,et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. , 1994, Circulation.